Dr. Sandrine Tinton

Sandrine qualified as pharmacist and obtained her PhD in Pharmaceutical Sciences at UCLouvain (Brussels, Belgium) in 1994 in collaboration with the Dept of Toxicology of the Karolinska Institute (Stockholm, Sweden). She trained as a postdoctoral fellow at the Dept for Molecular Biomedical Research (VIB-UGent, Belgium) and worked over 10 years as senior scientist in academic research laboratories. In 2007, Sandrine joined the Federal Agency for Medicinal and Health Products (FAMHP, Brussels), a Belgian National Competent Authority and she is currently a non-clinical assessor at the FAMHP. As a senior regulator, she is responsible for the evaluation of the non-clinical data (pharmacology, PK and toxicology) of medicinal products through all their stages of development from first in human clinical trial application until marketing authorization at both national and European Levels. Her non-clinical expertise mainly concerns the biotechnology-derived pharmaceuticals, the oligonucleotide therapeutics, and the nanomedicines.